The U.S. Supreme Court on Wednesday heard arguments from Teva Pharmaceutical Industries in defense of the patent protecting its $4 billion multiple sclerosis drug Copaxone, according to a Reuters report.
Pharmacies in Europe are reportedly stealing market share from beauty retailers like Sephora as they increasingly stock their shelves with natural and organic cosmetic brands, and consumers look to curb spending on higher-priced products, according to a Reuters report.
Pilgrim's Pride Corp., the world's second-largest chicken producer, as well as one of the world's biggest protein companies, is in talks to acquire Hillshire Brands for $6.4 billion, according to a report from Reuters.
Despite the massive data breach that hurt Target’s fourth quarter, people are not staying away from the retailer. According to a Reuters report, the company saw a dramatic improvement in traffic in the first quarter compared with its late fourth-quarter trends.
This year the 18th Annual Webby Awards, an international award honoring excellence on the Internet, featured applications for health and wellness mobile health apps, including CVS/pharmacy, Walgreens and GlaxoSmithKline.
Danish pharmaceutical group Alk Abello, in association with Merck, expects to start selling its new dust mite allergy tablet in the United States in 2017, according to a Reuters report published Thursday.
John Mulligan, EVP and CFO of Target, said the retailer is deeply sorry for its late 2013 data security breach and is aware that consumer confidence in the company is shaken; his comments came during a Feb. 4 testimony before the Senate Judiciary Committee.
The Council for Responsible Nutrition helped to tone down the conclusions of a recent study reported by Reuters Health that found vitamin supplements marketed for infants and children contained more than the recommended amount of individual vitamins.